Details for Patent: 8,618,141
✉ Email this page to a colleague
Summary for Patent: 8,618,141
Title: | Aryl ureas with angiogenesis inhibiting activity |
Abstract: | This invention relates to methods of using aryl ureas to treat diseases mediated by the VEGF induced signal transduction pathway characterized by abnormal angiogenesis or hyperpermeability processes. |
Inventor(s): | Dumas; Jacques (Bethany, CT), Scott; William J. (Guilford, CT), Elting; James (Madison, CT), Hatoum-Makdad; Holia (Hamden, CT) |
Assignee: | Bayer Healthcare LLC (Whippany, NJ) |
Application Number: | 13/551,884 |
Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for patent 8,618,141 |
Patent Claim Types: see list of patent claims | Use; Formulation; |
Drugs Protected by US Patent 8,618,141
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 8,618,141
Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
---|---|---|---|---|---|
Australia | 2003209116 | ⤷ Try a Trial | |||
Canada | 2475703 | ⤷ Try a Trial | |||
Cyprus | 1114314 | ⤷ Try a Trial | |||
Denmark | 1478358 | ⤷ Try a Trial | |||
European Patent Office | 1478358 | ⤷ Try a Trial | |||
European Patent Office | 2324825 | ⤷ Try a Trial | |||
>Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |